Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression

Abstract

Gastric carcinoma is one of the most common malignancies and a lethal cancer in the world. Notch signaling and transcription factors STAT3 (signal transducer and activator of transcription 3) and Twist regulate tumor development and are critical regulators of gastric cancer progression. Herein, the relationship among Notch, STAT3 and Twist pathways in the control of gastric cancer progression was studied. We found that Twist and phosphorylated STAT3 levels were promoted by the activated Notch1 receptor in human stomach adenocarcinoma SC-M1, embryonic kidney HEK293 and erythroleukemia K562 cells. Notch1 signaling dramatically induced Twist promoter activity through a C promoter binding factor-1-independent manner and STAT3 phosphorylation. Overexpression of Notch1 receptor intracellular domain (N1IC) enhanced the interaction between nuclear STAT3 and Twist promoter in cells. Gastric cancer progression of SC-M1 cells was promoted by N1IC through STAT3 phosphorylation and Twist expression including colony formation, migration and invasion. STAT3 regulated gastric cancer progression of SC-M1 cells via Twist. N1IC also elevated the progression of other gastric cancer cells such as AGS and KATO III cells through STAT3 and Twist. The N1IC-promoted tumor growth and lung metastasis of SC-M1 cells in mice were suppressed by the STAT3 inhibitor JSI-124 and Twist knockdown. Furthermore, Notch1 and Notch ligand Jagged1 expressions were significantly associated with phosphorylated STAT3 and Twist levels in gastric cancer tissues of patients. Taken together, these results suggest that Notch1/STAT3/Twist signaling axis is involved in progression of human gastric cancer and modulation of this cascade has potential for the targeted combination therapy.

MicroRNA-144 functions as a tumor suppressor in gastric cancer by targeting cyclooxygenase-2

“…The mortality rate of patients with GC is increasing in developing countries, particularly in East Asian countries (30). The overall 5-year survival rate remains low; ranging between 20-30% for patients past the early stage of the disease at the time of their initial diagnosis (31).…”

The Lauren Classification Highlights the Role of Epithelialto- Mesenchymal Transition in Gastric Carcinogenesis: an Immunohistochemistry Study of the STAT3 and Adhesion Molecules Expression

“…Furthermore, this resistance is associated with the activation of Stat3 and EMT [19,57]. The molecular interaction of STAT3 and Snail, ZIP6, and also the other transcription factors suggests that it is part of a core that controls EMT in normal and pathological conditions [58,59]. These data highlight the central role of STAT3, which could suggest that it could be a therapeutic target, its inhibition leading to a decrease in the main characteristics of tumor cells: proliferation, motility, invasion and upregulation of apoptosis.…”

MiR-421 Regulates Apoptosis of BGC-823 Gastric Cancer Cells by Targeting Caspase-3

“…Consequently, the five-year survival rate is low, ranging from 5 to 15% (Yu et al, 2009;Hsu et al, 2012). In 2008, the incidence rate of gastric cancer (0.738 million mortalities and 0.98 million new cases) ranked it as the second leading cause of cancer all over the world (Jemal et al, 2011).…”